the potential in the hiv vaccine is still being significantly underestimated
not concerned by this news. Pfizer had production problems like this too. Although tragic, when mass producing vaccines and outsourcing production at this scale, there are bound to be aberrant mistakes. This is precisely why the companies do not want to "lift patents " to try and maintain quality control. Firmly believe the potential in the hiv vaccine is still being significantly underestimated
$Moderna, Inc.(MRNA)$
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
